product summary
request information :
company name :
LifeSpan Biosciences
product type :
antibody
product name :
Anti-WT1 / Wilms Tumor 1 Antibody (N-Terminus, clone CAN-R9(IHC)-56-2) LS-C105719
catalog :
LS-C105719
clonality :
monoclonal
host :
rabbit
reactivity :
human
application :
western blot, immunohistochemistry - paraffin section
product information
?AntibodyID :
107597
AntibodyName :
LS-C105719
TargetSpecies :
Human
Host Species :
Rabbit
Product Name :
Anti-WT1 / Wilms Tumor 1 Antibody (N-Terminus, clone CAN-R9(IHC)-56-2) LS-C105719
ClonalityDesc :
Monoclonal
CloneName :
CAN-R9(IHC)-56-2
AntigenModification :
N-Terminus
PresentationDesc :
Tris-Glycine-NaCl or PBS, pH 7.2-7.4, 40-50% Glycerol, 0.01% sodium azide, 0.05% BSA
ImmunogenDesc :
A recombinant protein corresponding to the N-terminus of human WT was used as an immunogen.
PurificationDesc :
Tissue culture supernatant
RecommendedStorageDesc :
Store at -20°C. Aliquot to avoid freeze/thaw cycles. Store undiluted.
IsotypeName :
IgG
Gene :
WT1 / Wilms Tumor 1
StandardGeneSymbol :
WT1
Reactivity :
Human, Mouse
Usage :
IHC-P (1:100 - 1:250), WB (1:1000 - 1:10000)
UsageNotRecommended :
Flo, IP
Synonyms :
WT1, GUD, EWS-WT1, Amino-terminal domain of EWS, WAGR, WIT-2, Wilms tumor protein, AWT1, Wilms tumor 1, WT33, NPHS4
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
antibodies@lsbio.com
www.lsbio.com
1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.